Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer
NCT ID: NCT02254941
Last Updated: 2022-03-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1104 participants
OBSERVATIONAL
2014-08-31
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Target-Guided Chemotherapy in Metastatic Colorectal Patients
NCT01453257
Genotyping of Metastatic Colorectal Cancer Patients for Precision Medicine Clinical Trials
NCT03350412
Retrospective Study on the Use of Immunotherapy in Patients With MSI-H Metastatic Colorectal Cancer
NCT04612309
Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic
NCT01703910
Randomized Trial With Dendritic Cells in Patients With Metastatic Colorectal Cancer
NCT01413295
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active comparator: Chemotherapy
Metastatic colon cancer and first line treatment with conventional chemotherapy without monoclonal antibody.
Chemotherapy
Metastatic colon cancer, first line treatment with conventional chemotherapy
Experimental: Chemotherapy plus mAb
Metastatic colon cancer and first line treatment with conventional chemotherapy plus monoclonal antibody
Chemotherapy plus monoclonal antibody
Metastatic colon cancer, first line treatment with conventional chemotherapy plus monoclonal antibody
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Chemotherapy
Metastatic colon cancer, first line treatment with conventional chemotherapy
Chemotherapy plus monoclonal antibody
Metastatic colon cancer, first line treatment with conventional chemotherapy plus monoclonal antibody
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ECOG PS0-2.
* Who have not received prior chemotherapy treatment for metastatic disease.
* Measurable or evaluable disease.
* No previous surgery for metastatic disease. Surgery for metastasis allowed after inclusion in the study aftercare at the discretion of investigadors.
* Chemotherapy treatment with doublets (CAPOX, FOLFOX, FOLFIRI)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Grupo Espanol Multidisciplinario del Cancer Digestivo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joan Maurel, MD PhD
Role: STUDY_CHAIR
Hospital Clinic of Barcelona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Virgen de los Lirios
Alcoy, Alicante, Spain
Hospital General Universitario de Elche
Elche, Alicante, Spain
Hospital Universitario del Vinalopó
Elche, Alicante, Spain
Hospital General Universitario de Elda
Elda, Alicante, Spain
Hospital Universitario de Torrevieja
Torrevieja, Alicante, Spain
Hospital Clínico Universitario Lozano Blesa
Zaragoza, Aragon, Spain
Hospital Granollers
Granollers, Barcelona, Spain
Corporació Sanitària Parc Taulí
Sabadell, Barcelona, Spain
Hospital General de Catalunya
Sant Cugat del Vallès, Barcelona, Spain
Hospital de Terrasa
Terrassa, Barcelona, Spain
Hospital General de Vic
Vic, Barcelona, Spain
Hospital Universitario Virgen del Puerto de Plasencia
Plasencia, Cáceres, Spain
Hospital de Donostia
San Sebastián, Guipúzcoa, Spain
Centro Oncologico de Galicia
A Coruña, La Coruña, Spain
Hospital Universitario de Gran Canaria Doctor Negrín
Las Palmas de Gran Canaria, Las Palmas, Spain
Hospital Universitario Puerta de Hierro de Majadahonda
Majadahonda, Madrid, Spain
Hospital Son Espases
Palma, Malllorca, Spain
Hospital Universitario Virgen de la Arrixaca
El Palmar, Murcia, Spain
Hospital Costa del Sol
Marbella, Málaga, Spain
Clínica Universidad de Navarra
Pamplona, Navarre, Spain
Hospital Lluis Alcanyis de Xátiva
Xàtiva, Valencia, Spain
Hospital Obispo Polanco
Teruel, Zaragoza, Spain
Hospital Infanta Cristina de Badajoz
Badajoz, , Spain
Centre Mèdic Teknon
Barcelona, , Spain
Hospital de la Santa Creu i Sant Pau
Barcelona, , Spain
Hosptial de l'Esperit Sant de Barcelona
Barcelona, , Spain
Hospital Clinic i Provincial
Barcelona, , Spain
Hospital Plató
Barcelona, , Spain
Hospital Universitari Sagrat Cor
Barcelona, , Spain
Consorcio Hospitalario Provincial de Castellón
Castelló, , Spain
Hospital San Pedro de Alcantara Cáceres
Cáceres, , Spain
Hospital General de Ciudad Real
Ciudad Real, , Spain
Hospital Univeritari Dr. Josep Trueta
Girona, , Spain
Hospital Arnau de Vilanova de Lleida
Lleida, , Spain
Hospital Universitario Fundación Jiménez Díaz
Madrid, , Spain
Hospital La Paz
Madrid, , Spain
Hospital Althaia
Manresa, , Spain
Hospital Virgen de la Victoria
Málaga, , Spain
Hospital Morales Meseguer
Murcia, , Spain
Complejo Hospitalario Universitario de Ourense
Ourense, , Spain
Hospital Universitari Son Llàtzer
Palma de Mallorca, , Spain
Hospital Provincial de Pontevedra
Pontevedra, , Spain
Hospital de Sagunto
Sagunto, , Spain
Instituto Valenciano de Oncologia
Valencia, , Spain
Hospital Doctor Peset
Valencia, , Spain
Hospital Universitario y Politécnico de La Fe
Valencia, , Spain
Complejo Hospitalario Universitario de Vigo
Vigo, , Spain
Hospital Miguel Servet
Zaragoza, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GEMCAD 1401
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.